FDA Inspection 1096100 — Regional Women's Health Group, LLC

Regional Women's Health Group, LLC — FEI 3004088908

The FDA completed an inspection of Regional Women's Health Group, LLC on Jul 12, 2019 in Marlton, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Biologics.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Jul 12, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Marlton, NJ (United States)

Citations

IDCFRDescription
1227721 CFR 1271.75(a)(1)Risk factors, clinical evidence
1249221 CFR 1271.85(a)Infection with communicable disease agents

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.